VANGUARD GROUP INC 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 6:06 pm Sale | 2026-03-13 | 13G | ENANTA PHARMACEUTICALS INC ENTA | VANGUARD GROUP INC | 0 0.000% | -1,793,786 (Position Closed) | Filing |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | ENANTA PHARMACEUTICALS INC ENTA | VANGUARD GROUP INC | 1,793,786 8.520% | 271,597 (+17.84%) | Filing |
| 2023-02-09 11:19 am Sale | 2022-12-30 | 13G | ENANTA PHARMACEUTICALS INC ENTA | VANGUARD GROUP INC | 1,522,189 7.320% | -103,720 (-6.38%) | Filing |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | ENANTA PHARMACEUTICALS INC ENTA | VANGUARD GROUP INC | 1,625,909 8.000% | -174,670 (-9.70%) | Filing |